Vaccination greatly reduces disease, disability, death and inequity worldwide von ANDRE, F. E, BOOY, R, SANTOSHAM, M, SCHMITT, H. J, BOCK, H. L, DEMENS, J, DATTA, S. K, JOHN, T. J, LEE, B. W, LOLEKHA, S, PELTOLA, H, RUFF, T. A

Volltext

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus von Kato, Eri T, Silverman, Michael G, Mosenzon, Ofri, Zelniker, Thomas A, Cahn, Avivit, Furtado, Remo H.M, Kuder, Julia, Murphy, Sabina A, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P.H, Bonaca, Marc P, Ruff, Christian T, Desai, Akshay S, Goto, Shinya, Johansson, Peter A, Gause-Nilsson, Ingrid, Johanson, Per, Langkilde, Anna Maria, Raz, Itamar, Sabatine, Marc S, Wiviott, Stephen D

Volltext

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials von Ruff, Christian T, Dr, Giugliano, Robert P, MD, Braunwald, Eugene, Prof, Hoffman, Elaine B, PhD, Deenadayalu, Naveen, MPH, Ezekowitz, Michael D, Prof, Camm, A John, Prof, Weitz, Jeffrey I, Prof, Lewis, Basil S, Prof, Parkhomenko, Alexander, Prof, Yamashita, Takeshi, Prof, Antman, Elliott M, Prof

Volltext

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial von De Caterina, Raffaele, MD, PhD, Renda, Giulia, MD, PhD, Carnicelli, Anthony P., MD, Nordio, Francesco, PhD, Trevisan, Marco, MSc, Mercuri, Michele F., MD, Ruff, Christian T., MD, MPH, Antman, Elliott M., MD, Braunwald, Eugene, MD, Giugliano, Robert P., MD, SM

Volltext

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients von Bohula, Erin A, Wiviott, Stephen D, McGuire, Darren K, Inzucchi, Silvio E, Kuder, Julia, Im, KyungAh, Fanola, Christina L, Qamar, Arman, Brown, Conville, Budaj, Andrzej, Garcia-Castillo, Armando, Gupta, Milan, Leiter, Lawrence A, Weissman, Neil J, White, Harvey D, Patel, Tushar, Francis, Bruce, Miao, Wenfeng, Perdomo, Carlos, Dhadda, Shobha, Bonaca, Marc P, Ruff, Christian T, Keech, Anthony C, Smith, Steven R, Sabatine, Marc S, Scirica, Benjamin M

Volltext

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial von Ruff, Christian T, Dr, Giugliano, Robert P, MD, Braunwald, Eugene, Prof, Morrow, David A, MD, Murphy, Sabina A, MPH, Kuder, Julia F, MA, Deenadayalu, Naveen, MPH, Jarolim, Petr, MD, Betcher, Joshua, PhD, Shi, Minggao, PhD, Brown, Karen, PhD, Patel, Indravadan, MD, Mercuri, Michele, MD, Antman, Elliott M, Prof

Volltext

Left atrial structure and function and the risk of death or heart failure in atrial fibrillation von Inciardi, Riccardo M., Giugliano, Robert P., Claggett, Brian, Gupta, Deepak K., Chandra, Alvin, Ruff , Christian T., Antman, Elliott M., Mercuri, Michele F., Grosso, Michael A., Braunwald, Eugene, Solomon, Scott D.

Volltext

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial von Kato, Eri Toda, Giugliano, Robert P., Ruff, Christian T., Koretsune, Yukihiro, Yamashita, Takeshi, Kiss, Robert Gabor, Nordio, Francesco, Murphy, Sabina A., Kimura, Tetsuya, Jin, James, Lanz, Hans, Mercuri, Michele, Braunwald, Eugene, Antman, Elliott M.

Volltext

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism von Marston, Nicholas A., Gurmu, Yared, Melloni, Giorgio E.M., Bonaca, Marc, Gencer, Baris, Sever, Peter S., Pedersen, Terje R., Keech, Anthony C., Roselli, Carolina, Lubitz, Steven A., Ellinor, Patrick T., O’Donoghue, Michelle L., Giugliano, Robert P., Ruff, Christian T., Sabatine, Marc S.

Volltext

Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation von Ravvaz, Kourosh, Weissert, John A, Jahangir, Arshad, Ruff, Christian T

Volltext

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48 von Gupta, Deepak K, Shah, Amil M, Giugliano, Robert P, Ruff, Christian T, Antman, Elliott M, Grip, Laura T, Deenadayalu, Naveen, Hoffman, Elaine, Patel, Indravadan, Shi, Minggao, Mercuri, Michele, Mitrovic, Veselin, Braunwald, Eugene, Solomon, Scott D

Volltext

The importance of dosing frequency on the safety of DOACs von Ruff, Christian T.

Volltext

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial von Fanola, Christina L, Ruff, Christian T, Murphy, Sabina A, Jin, James, Duggal, Anil, Babilonia, Noe A, Sritara, Piyamitr, Mercuri, Michele F, Kamphuisen, Pieter W, Antman, Elliott M, Braunwald, Eugene, Giugliano, Robert P

Volltext

Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation　– An ENGAGE AF-TIMI 48 Subanalysis von Yamashita, Takeshi, Koretsune, Yukihiro, Yang, Yuejin, Chen, Shih-Ann, Chung, Namsik, Shimada, Yuichi J., Kimura, Tetsuya, Miyazaki, Koichi, Abe, Kenji, Mercuri, Michele, Ruff, Christian T., Giugliano, Robert P.

Volltext

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor... von Ruff, Christian T., MD, Giugliano, Robert P., MD, SM, Antman, Elliott M., MD, Crugnale, Sharon E., MS, Bocanegra, Tomas, MD, Mercuri, Michele, MD, PhD, Hanyok, James, PharmD, Patel, Indravadan, MD, Shi, Minggao, PhD, Salazar, Dan, PhD, McCabe, Carolyn H., BS, Braunwald, Eugene, MD

Volltext

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial von Mega, Jessica L, Dr, Walker, Joseph R, PharmD, Ruff, Christian T, MD, Vandell, Alexander G, PhD, Nordio, Francesco, PhD, Deenadayalu, Naveen, MPH, Murphy, Sabina A, MPH, Lee, James, PhD, Mercuri, Michele F, MD, Giugliano, Robert P, MD, Antman, Elliott M, Prof, Braunwald, Eugene, Prof, Sabatine, Marc S, Dr Prof

Volltext

No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab von Korthauer, Laura E, Giugliano, Robert P, Guo, Jianping, Sabatine, Marc S, Sever, Peter, Keech, Anthony, Atar, Dan, Kurtz, Christopher, Ruff, Christian T, Mach, Francois, Ott, Brian R

Volltext

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial von Fanola, Christina L, Giugliano, Robert P, Ruff, Christian T, Trevisan, Marco, Nordio, Francesco, Mercuri, Michele F, Antman, Elliott M, Braunwald, Eugene

Volltext

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial von Xu, Haiyan, Ruff, Christian T., Giugliano, Robert P., Murphy, Sabina A., Nordio, Francesco, Patel, Indravadan, Shi, Minggao, Mercuri, Michele, Antman, Elliott M., Braunwald, Eugene

Volltext

Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation von Oyama, Kazuma, Giugliano, Robert P., Ruff, Christian T., Berg, David D., Jarolim, Petr, Tang, Minao, Park, Jeong‐Gun, Lanz, Hans J., Antman, Elliott M., Braunwald, Eugene, Morrow, David A.

Volltext